Get started
Author

Martin J. Kohlhaeufl

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
2017 · Leora Horn, David R. Spigel, et al. · Journal of Clinical Oncology · 875
Clinical perspectives on pulmonary systemic and macromolecular delivery
2006 · Gerhard Scheuch, Martin J. Kohlhaeufl, et al. · Advanced Drug Delivery Reviews · 182
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
2015 · Luis Paz-Ares, Leora Horn, et al. · Journal of Clinical Oncology · 149
Phase II Trial of a Trimodality Regimen for Stage III Non–Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Center Study
2010 · Godehard Friedel, Wilfried Budach, et al. · Journal of Clinical Oncology · 77
Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
2016 · Francesco Bonella, Michael Kreuter, et al. · Respiration · 68
PDF
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
2016 · Jonathan W. Goldman, Lucio Crino, et al. · Journal of Thoracic Oncology · 43
Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).
2016 · Jonathan Wade Goldman, Lucio Crino, et al. · Journal of Clinical Oncology · 37
MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
2012 · Eric Dansin, Saverio Cinieri, et al. · Lung Cancer · 37
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
2015 · Luis Paz-Ares, Leora Horn, et al. · Journal of Clinical Oncology · 34
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome
2011 · R. F. Falkenstern-Ge, M. Kimmich, et al. · Journal of Cancer Research and Clinical Oncology · 19
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
2017 · Wolfgang Schuette, Claus-Peter Schneider, et al. · Lung Cancer Targets and Therapy · 9
PDF
65 plus: A randomized phase III trial of pemetrexed and bevacizumab versus pemetrexed, bevacizumab, and carboplatin as first-line treatment for elderly patients with advanced nonsquamous, non-small cell lung cancer (NSCLC).
2013 · Wolfgang Schuette, Sylke Nagel, et al. · Journal of Clinical Oncology · 8
Treatment of Severe Advanced Emphysema With Volume Reduction Using Lung Sealant
2013 · Roger F. Falkenstern-Ge, Hermann Ingerl, et al. · Journal of Bronchology & Interventional Pulmonology · 3
3077 65 plus: A randomized phase III trial of Pemetrexed and Bevacizumab vs. Pemetrexed, Bevacizumab and Carboplatin as 1st line treatment for elderly patients with advanced non-squamous, non-small cell lung cancer (NSCLC) - a subgroup analysis of age and gender
2015 · W. Schuette, B. Nieman, et al. · European Journal of Cancer · 2
Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
2014 · Martin J. Kohlhaeufl, Hermann Ingerl, et al. · European Respiratory Journal · 1
Insights From A Multi-Centre Real Life Experience In Germany With Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis
2016 · Francesco Bonella, Michael Kreuter, et al. · American Journal of Respiratory and Critical Care Medicine
Supplementary Material for: Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
2016 · Bonella, F., Kreuter, M., et al. · Figshare
65 plus: Eine randomisierte Phase-III Studie über Pemetrexed und Bevacizumab versus Pemetrexed, Bevacizumab und Carboplatin als 1st-line Chemotherapie für ältere Patienten mit nicht-plattenepithel NSCLC
2014 · K Reuse, S Nagel, et al. · Pneumologie
Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
2013 · R. F. Falkenstern-Ge, Martin Kimmich, et al. · European Respiratory Journal
Works count: 20
Citation count: 1,544
H-index: 10
I10-index: 10
Year
Topic
Type